Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124541193 | 12454119 | 3 | F | 20160603 | 20160719 | 20160610 | 20160722 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-044494 | BRISTOL MYERS SQUIBB | 56.32 | YR | F | Y | 0.00000 | 20160722 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124541193 | 12454119 | 1 | PS | SPRYCEL | DASATINIB | 1 | Oral | 100 MG, QD | U | 21986 | 100 | MG | FILM-COATED TABLET | QD | |||||
124541193 | 12454119 | 2 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124541193 | 12454119 | 1 | Metastases to bone |
124541193 | 12454119 | 2 | Product used for unknown indication |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124541193 | 12454119 | Biopsy | |
124541193 | 12454119 | Photosensitivity reaction | |
124541193 | 12454119 | Product use issue | |
124541193 | 12454119 | Pruritus generalised | |
124541193 | 12454119 | Rash pruritic |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124541193 | 12454119 | 1 | 20151209 | 0 |